These findings suggest that NY-ESO-1 and MAGE-A4 could serve as predictive markers in soft tissue sarcomas and other malignancies with a high metastatic propensity, such as locally advanced rectal cancer [42]. The gene discussed is MAGEA4; the disease is soft tissue sarcoma.